The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Inflammatory Bowel Disease: A Canadian Burden of Illness Review
Open accessAbstract
BACKGROUND: Inflammatory bowel diseases (IBD) – Crohn’s disease (CD) and ulcerative colitis (UC) – significantly impact quality of life and account for substantial costs to the health care system and society. OBJECTIVE: To conduct a comprehensive review and summary of the burden of IBD that encompasses the epidemiology, direct medical costs, indirect costs and humanistic impact of these diseases in Canada. METHODS: A literature search focused on Canadian data sources. Analyses were applied to the current 2012 Canadian population. RESULTS: There are approximately 233,000 Canadians living with IBD in 2012 (129,000 individuals with CD and 104,000 with UC), corresponding to a prevalence of 0.67%. Approximately 10,200 incident cases occur annually. IBD can be diagnosed at any age, with typical onset occurring in the second or third decade of life. There are approximately 5900 Canadian children <18 years of age with IBD. The economic costs of IBD are estimated to be $2.8 billion in 2012 (almost $12,000 per IBD patient). Direct medical costs exceed $1.2 billion per annum and are driven by cost of medications ($521 million), hospitalizations ($395 million) and physician visits ($132 million). Indirect costs (society and patient costs) total $1.6 billion and are dominated by long-term work losses of $979 million. Compared with the general population, the quality of life patients experience is low across all dimensions of health. CONCLUSIONS: The present review documents a high burden of illness from IBD due to its high prevalence in Canada combined with high per-patient costs. Canada has among the highest prevalence and incidence rates of IBD in the world. Individuals with IBD face challenges in the current environment including lack of awareness of IBD as a chronic disease, late or inappropriate diagnosis, inequitable access to health care services and expensive medications, diminished employment prospects and limited community-based support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Self-citationEpidemiology of pediatric inflammatory bowel disease: A systematic review of international trends
Benchimol, E. I., Fortinsky, K. J., Gozdyra, P., Van den Heuvel, M., Van Limbergen, J., & Griffiths, A. M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21349 · Cited by 954
Self-citationThe Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study
Bernstein, C. N., Wajda, A., Svenson, L. W., MacKenzie, A., Koehoorn, M., Jackson, M., Fedorak, R., Israel, D., & Blanchard, J. F. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00603.x · Cited by 636
Self-citationBenchimol, E. I., Guttmann, A., Griffiths, A. M., Rabeneck, L., Mack, D. R., Brill, H., Howard, J., Guan, J., & To, T. (2009) · Gut · doi:10.1136/gut.2009.188383 · Cited by 414
Self-citationJess, T., Riis, L., Vind, I., Winther, K. V., Borg, S., Binder, V., Langholz, E., Thomsen, O. S., & Munkholm, P. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20036 · Cited by 394
Luo, N., Johnson, J. A., Shaw, J. W., Feeny, D., & Coons, S. J. (2005) · Medical Care · doi:10.1097/01.mlr.0000182493.57090.c1 · Cited by 383
Silverstein, M. D., Loftus, E. V., Sandborn, W. J., Tremaine, W. J., Feagan, B. G., Nietert, P. J., Harmsen, W. S., & Zinsmeister, A. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70549-4 · Cited by 354
Self-citationA population-based study of fatigue and sleep difficulties in inflammatory bowel disease
Graff, L. A., Vincent, N., Walker, J. R., Clara, I., Carr, R., Ediger, J., Miller, N., Rogala, L., Rawsthorne, P., Lix, L., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21580 · Cited by 294
Self-citationHospitalisations and surgery in Crohn's disease
Bernstein, C. N., Loftus, E. V., Ng, S. C., Lakatos, P. L., & Moum, B. (2012) · Gut · doi:10.1136/gutjnl-2011-301397 · Cited by 294
Self-citationGraff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Jakul, L., McPhail, C., Ediger, J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.027 · Cited by 292
Self-citationHøivik, M. L., Moum, B., Solberg, I. C., Henriksen, M., Cvancarova, M., Bernklev, T., & IBSEN Group (2013) · Gut · doi:10.1136/gutjnl-2012-302311 · Cited by 260
Rising incidence of pediatric inflammatory bowel disease in Scotland*
Henderson, P., Hansen, R., Cameron, F. L., Gerasimidis, K., Rogers, P., Bisset, M. W., Reynish, E. L., Drummond, H. E., Anderson, N. H., Van Limbergen, J., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21797 · Cited by 242
Lix, L. M., Graff, L. A., Walker, J. R., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Ediger, J., Pretorius, T., & Bernstein, C. N. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20511 · Cited by 238 · cited 1×
“Even those without symptoms experience psychological distress (stress, anxiety, fear about pain and worry about the consequences of their disease) (41,42).”
BackgroundBernklev, T., Jahnsen, J., Lygren, I., Henriksen, M., Vatn, M., & Moum, B. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000179467.01748.99 · Cited by 238
Longobardi, T. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06007-0 · Cited by 196
Annual cost of care for Crohn's disease: a payor perspective
Feagan, B. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01053-4 · Cited by 193
Self-citationNguyen, G. C., Nugent, Z., Shaw, S., & Bernstein, C. N. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.050 · Cited by 184
Self-citationThe Effects of Infliximab Therapy on Health-Related Quality of Life in Ulcerative Colitis Patients
Feagan, B. G., Reinisch, W., Rutgeerts, P., Sandborn, W. J., Yan, S., Eisenberg, D., Bala, M., Johanns, J., Olson, A., & Hanauer, S. B. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01094.x · Cited by 178
Self-citationBernklev, T., Jahnsen, J., Aadland, E., Sauar, J., Schulz, T. B., Lygren, I., Henriksen, M., Stray, N., Kjellevold, Ø., Vatn, M., et al. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310008386 · Cited by 151
Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study
Lehtinen, P., Ashorn, M. H., Iltanen, S., Jauhola, R., Jauhonen, P., Kolho, K., & Auvinen, A. P. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21550 · Cited by 141
Meta‐analysis: mortality in Crohn’s disease
Canavan, C., Abrams, K. R., & Mayberry, J. F. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03276.x · Cited by 135
Hilsden, R. J., Verhoef, M. J., Best, A., & Pocobelli, G. S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07519.x · Cited by 129
Costs of Inflammatory Bowel Disease in Germany
Stark, R. G., nig, H.-H. K., & Leidl, R. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624080-00006 · Cited by 129
van der Zaag–Loonen, H. J., Grootenhuis, M., Last, B. F., Koopman, H., & Derkx, H. H. F. (2002) · Acta Paediatrica · doi:10.1080/08035250252834049 · Cited by 114
Boer, M. D., Grootenhuis, M. A., Derkx, B., & Last, B. F. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000164024.10848.0a · Cited by 114
Mortality by Medication Use Among Patients With Inflammatory Bowel Disease, 1996–2003
Hutfless, S. M., Weng, X., Liu, L., Allison, J. E., & Herrinton, L. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.022 · Cited by 100
Vidal, À., Gómez‐Gil, E., Sans, M., Portella, M. J., Salamero, M., Pique, J. M., & Panés, J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20388 · Cited by 99
Longobardi, T., Jacobs, P., Wu, L., & Bernstein, C. N. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07378.x · Cited by 99
Self-citationBenchimol, E. I., To, T. M., Griffiths, A. M., Rabeneck, L., & Guttmann, A. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.11.039 · Cited by 95
Self-citationBernklev, T., Jahnsen, J., Schulz, T. B., Sauar, J., Lygren, I., Henriksen, M., Stray, N., Kjellevold, Y., Aadland, E., Vatn, M., et al. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200510000-00006 · Cited by 93
Benchimol, E. I., Guttmann, A., To, T. M., Rabeneck, L., & Griffiths, A. M. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21591 · Cited by 89
Self-citationDirect Medical Cost of Managing IBD Patients: A Canadian Population-based Study
Bernstein, C. N., Longobardi, T., Finlayson, G., & Blanchard, J. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21878 · Cited by 87
Self-citationHealth Care Resource Utilization in Inflammatory Bowel Disease
Longobardi, T., & Bernstein, C. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.013 · Cited by 83
Self-citationHøie, O., Schouten, L. J., Wolters, F. J., Solberg, I. C., Riis, L. B., Mouzas, I., Politi, P., Odes, S. H., Langholz, E., Vatn, M., et al. (2006) · Gut · doi:10.1136/gut.2006.101519 · Cited by 82
Buxton, M. J., Lacey, L. A., Feagan, B. G., Niecko, T., Miller, D. W., & Townsend, R. J. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00171.x · Cited by 78
Self-citationEmployment problems and prospects for patients with inflammatory bowel disease.
Wyke, R. J., EDWARDS, F. C., & Allan, R. N. (1988) · Gut · doi:10.1136/gut.29.9.1229 · Cited by 73
Epidemiology of Crohnʼs Disease in QuéBec, Canada
Lowe, A., Roy, P.-O., Bigras-Poulin, M., Michel, P., Bitton, A., St-Onge, L., & Brassard, P. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20756 · Cited by 67
Self-citationRawsthorne, P. E., Clara, I. P., Graff, L. A., Bernstein, K. I., Carr, R., Walker, J. R., Ediger, J. P., Rogala, L., Miller, N., & Bernstein, C. N. (2011) · Gut · doi:10.1136/gutjnl-2011-300219 · Cited by 67
Self-citationGibson, P. R., Weston, A. R., Shann, A., Florin, T. H., Lawrance, I. C., Macrae, F., & Radford‐Smith, G. L. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04930.x · Cited by 64
Rutgeerts, P. J., Schreiber, S., Feagan, B. G., Keininger, D. L., O’Neil, L., Fedorak, R. N., & CDP870 Crohn’s Disease Study Group (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-007-0395-7 · Cited by 57
Self-citationCamilleri‐Brennan, J., & Steele, R. J. (2001) · PubMed Central · Cited by 55
Gender and disease activity influence health-related quality of life in inflammatory bowel diseases.
Saibeni, S., Cortinovis, I., Beretta, L., Tatarella, M., Ferraris, L., Rondonotti, E., Corbellini, A., Bortoli, A., Colombo, E., Alvisi, C., et al. (2005) · PubMed · Cited by 54
A national survey on the patterns of treatment of inflammatory bowel disease in Canada
Hilsden, R. J., Verhoef, M. J., Best, A., & Pocobelli, G. S. (2003) · BMC Gastroenterology · doi:10.1186/1471-230x-3-10 · Cited by 39
Longobardi, T., & Bernstein, C. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01232.x · Cited by 38
Self-citationHealth-Related Quality of Life after Ileocolonic Resection for Crohnʼs Disease: Long-term Results
Scarpa, M., Ruffolo, C., Renata D'Incà, Filosa, T., Bertin, E., Ferraro, S., Polese, L., Martin, A., Sturniolo, G. C., Frego, M., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20080 · Cited by 29
Cited by
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Self-citationThe global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
The burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Zuo, T., & Ng, S. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02247 · Cited by 587
Depression and anxiety in patients with Inflammatory Bowel Disease: a systematic review
Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.06.001 · Cited by 561
Metadata
- Authors
- Rocchi, A., Benchimol, E. I., Bernstein, C. N., Bitton, A., Feagan, B., Panaccione, R., Glasgow, K. W., Fernandes, A., & Ghosh, S.
- Venue
- Canadian Journal of Gastroenterology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 26
- Issue
- 11
- Pages
- 811-817
- ISSN
- 0835-7900 (ISSN-L)
- OpenAlex
- W1592353726
- Cited by
- 286
- References
- 45
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.